Vhl) protein inhibits hypoxia-inducible factor (Hif), yet its deletion in murine retina does not cause the extensive angiogenesis expected with Hif induction. The mechanism is unclear. Here we show that retinoblastoma tumor suppressor (Rb1) constrains expression of Hif target genes in the Vhl -/retina. Deleting Rb1 induced extensive retinal neovascularization and autophagic ablation of photoreceptors in the Vhl -/retina. RNA-sequencing, ChIP, and reporter assays showed Rb1 recruitment to and repression of certain Hif target genes. Activating Rb1 by deleting cyclin D1 induced a partial defect in the retinal superficial vascular plexus. Unexpectedly, removing Vhl suppressed retinoblastoma formation in murine Rb1/Rbl1-deficient retina but generated subretinal vascular growths resembling retinal angiomatous proliferation (RAP) and retinal capillary hemangioblastoma (RCH). Most stromal cells in the RAP/RCH-like lesions were Sox9 + , suggesting a Müller glia origin, and expressed Lgals3, a marker of human brain hemangioblastoma. Thus, the Rb family limit Hif target gene expression in the Vhl -/retina, and removing this inhibitory signal generates new models for RAP and RCH. vascular plexuses, including the superficial vascular plexus (SVP) in the nerve fiber layer, deep vascular plexus (DVP) in the outer plexiform layer (OPL), and intermediate vascular plexus (IVP) in the inner plexiform layer (16).
Introduction
Retinal neovascularization is associated with multiple disorders such as retinopathy of prematurity, diabetic retinopathy, and age-related macular degeneration (AMD) (1, 2) . Retinal angiomatous proliferation (RAP) is one form of neovascular AMD, which is a leading cause of blindness in the world (3) . Neovascular AMD also includes 2 other forms, typical choroidal neovascularization (CNV) and polypoidal choroidal vasculopathy. RAP arises from deep retinal capillaries and develops from intraretinal (stage I), to subretinal (stage II), and finally to choroidal neovascularization and retinal-choroidal anastomosis (stage III) (4) . Pathologically, RAP is an intraretinal angiomatous complex within the outer retina (5, 6) . Although RAP follows a different natural course and response to treatment from typical CNV, few animal models are established to allow us to fully understand the pathogenesis or to test new treatments for late-stage disease, even though there are several mouse models of early-stage RAP (7) (8) (9) (10) (11) .
Retinal capillary hemangioblastoma (RCH) is the hallmark lesion of ocular von Hippel-Lindau (VHL) disease (12) . This multisystem tumor syndrome is caused by germline Vhl gene mutations and is also associated with many other tumors, such as brain hemangioblastoma and clear cell renal cell carcinomas (CCRCCs) (13) . Vhl protein is a component of the E3 ubiquitin ligase complex that targets hypoxia-inducible factor-α (Hif-α) for proteasomal degradation. Hif is the master regulator of the response to hypoxia because Hif-α accumulates and induces the transcription of genes involved in adaptation to hypoxia, including BCL2 interacting protein 3 (Bnip3), erythropoietin (Epo), and Vegfa (14) . Angiogenesis is critical for adaptation to hypoxia and retinal development and also influences or drives many retinal diseases. In murine newborn eyes, the hyaloid vessels in the vitreous regress, and the retinal vessels develop to supply blood to the retina (15) . The retinal vasculature consists of 3 parallel Von Hippel-Lindau (Vhl) protein inhibits hypoxia-inducible factor (Hif), yet its deletion in murine retina does not cause the extensive angiogenesis expected with Hif induction. The mechanism is unclear. Here we show that retinoblastoma tumor suppressor (Rb1) constrains expression of Hif target genes in the Vhl -/retina. Deleting Rb1 induced extensive retinal neovascularization and autophagic ablation of photoreceptors in the Vhl -/retina. RNA-sequencing, ChIP, and reporter assays showed Rb1 recruitment to and repression of certain Hif target genes. Activating Rb1 by deleting cyclin D1 induced a partial defect in the retinal superficial vascular plexus. Unexpectedly, removing Vhl suppressed retinoblastoma formation in murine Rb1/Rbl1-deficient retina but generated subretinal vascular growths resembling retinal angiomatous proliferation (RAP) and retinal capillary hemangioblastoma (RCH). Most stromal cells in the RAP/RCH-like lesions were Sox9 + , suggesting a Müller glia origin, and expressed Lgals3, a marker of human brain hemangioblastoma. Thus, the Rb family limit Hif target gene expression in the Vhl -/retina, and removing this inhibitory signal generates new models for RAP and RCH.
Results
Rb1 suppresses angiogenesis in the Vhl-null retina. To delete floxed ( fl ) Rb1 or Vhl alleles (20, 21, 34) , we used the α-Cre transgene, which is active from E10 in peripheral retinal progenitors (42) . We bred α-Cre Rb1 fl/fl (Rb1-KO) mice with Vhl fl/fl mice and quantified vessel growth using the endothelial marker isolectin B4 (IB4). As reported before (20, 21) , α-Cre Vhl fl/fl (Vhl-KO) mice demonstrated increased level of Hif-1α protein (Supplemental Figure 1 ; supplemental material available online with this article; https://doi. org/10.1172/jci.insight.127889DS1) and delayed regression of hyaloid vessels and retinal angiogenesis, but unlike VHL patients, lacked any evidence of vascular overgrowth, except a few vessels invaded into the outer nuclear layer (ONL) ( Figure 1, A and B) . Indeed, the protein levels of Vegfa and kinase insert domain receptor (Kdr) were normal (Supplemental Figure 1 ). In the Rb1/Vhl-double knockout (DKO) retina, hyaloid vessel regression was still delayed, but strikingly, there were many new blood vessels in the peripheral retina ( Figure 1, A and B) . These vessels penetrated throughout all retinal layers to form a dense capillary bed, and there was no normal SVP, IVP, or DVP ( Figure 1B) . To compare the vascular density to other genotypes, we used vascular images taken from similar depths below the ganglion cell layer (GCL) to represent the IVP and DVP for the DKO retina. The vascular density was 3-4 times higher than in WT retina ( Figure 1 , B and C).
These new blood vessels began to form at around P8, likely originating from both the existing retinal vasculature and the persistent hyaloid vessels (Supplemental Video 1), because they were linked to hyaloid vessels ( Figure 1D , arrowheads) and the DVP in the central retina ( Figure 1D , arrows). In the middle of the new vessel bed, there were many IB4 + "grape-like" clusters of endothelial cells ( Figure 1 , E and F). As the delayed hyaloid vessels blocked the fluorescein signal ( Figure 1G ), the retinal blood vessels of the live animal in fundus fluorescein angiography (FFA) were not clear, but neovascularization and vascular leakage could be documented at late stages ( Figure 1H , arrows). Retroorbital injection of FITC-dextran (43) demonstrated that the new vessels were leaking and clearly shunted to the persistent hyaloid vessels ( Figure 1I ). These new vessels persisted for at least 2 years ( Figure 1J ).
Rb1 loss alone causes apoptosis of certain retinal neurons, which indirectly impedes angiogenesis (40) . Cell loss is unlikely to explain the excessive angiogenesis in the Rb1/Vhl-null retina. However, in addition, Rb1 loss causes a transient period of ectopic division of all retinal cell types and disrupts lamination (34, 40) . To examine whether any of these Rb1-null phenotypes might explain the excessive vasculature in the Rb1/Vhl-null retina, we took 2 genetic approaches. The Rb1 +/retina is WT (34); thus we assessed the effect of removing 1 Rb1 allele on angiogenesis. Notably, this subtle genetic manipulation still induced retinal neovascularization in the Vhl -/retina ( Figure 1 , A-C). Moreover, vessel density was lower than in the Rb1/Vhl-DKO retina, revealing a dose-dependent role for Rb1 in limiting angiogenesis. Second, we assessed the effect of E2f1 on angiogenesis. Rb1 binds and inhibits E2f, and deleting E2f1 rescues all the ectopic cell division, cell death, and lamination defects seen in the Rb1-null retina (40, 44) . Importantly, E2f1 deletion did not rescue neovascularization in the Rb1/Vhl-DKO retina (Figure 1 , A-C). Together, these Rb1 +/and E2f1 -/data suggest that Rb1 inhibits vessel growth in the Vhl -/retina independent of its roles in controlling cell division, apoptosis, or lamination.
Rb1 suppresses loss of Vhl-null photoreceptors. The above data show that deleting Rb1 unleashes the proangiogenic effects associated with Vhl loss. Potentially, therefore, Rb1 also suppresses other phenotypes in this context. For example, although the number of all retinal cell types was normal in P18 Vhl-KO retina (Figure 2 , A-D), there is modest loss of photoreceptors in the Vhl -/retina around P30 (20) . But whether Rb1 limits this phenotype is unknown.
To assess this issue, we stained the P18 Rb1/Vhl-DKO retina with cell type-specific markers. As in the Rb1 -/tissue, the DKO retina was missing ganglion (Pou4f2 + ) and rod bipolar (Pkca + ) cells ( Figure 2 , A and B, and Supplemental Figure 2 ). Whereas the Rb1 -/retina retained many rod (Rho + ) and all cones (Arr3 + ) as reported before (34) , all photoreceptors were absent in the DKO tissue ( Figure 2 , A and B, and Supplemental Figure 2 ). To exclude the possibility that these neurons never formed in the DKO retina, we stained P0 DKO retina with Pou4f2, Crx (precursors of rod, cone, and bipolar cells), and Thrb2 (precursor of cones) (Supplemental Figure 3 ). Obviously all these neurons formed in the DKO retina. Thus, all Rb1/ Vhl-null excitatory neurons are generated but then die, indicating that Rb1 and Vhl loss are synthetically lethal to photoreceptors.
Similar to the Rb1 -/tissue, the P18 Rb1/Vhl-DKO retina retained inhibitory amacrine (Ap2a + ) and horizontal (Onecut2 + ) neurons, as well as Müller glia (Sox9 + ), and while the DKO tissue had similar numbers of horizontal cells, there were modest increases in the proportion of amacrine cells (~2-fold) and Müller glia (~1.5-fold) ( Figure 2 , C and D, and Supplemental Figure 2 ). These increases paralleled increased proliferation marker protein Ki-67 (Mki67) and phospho-histone H3 (PH3) indexes in the P18-DKO retinas (Supplemental Figure 4 , A and B). Although Müller cells kept dividing at P18, amacrine cells were mostly postmitotic at this point, suggesting that their slightly elevated numbers may reflect ectopic division at an early time point (Supplemental Figure 4 , C and D). In summary, therefore, while deleting Rb1 and Vhl modestly increases the number of 2 INL cell types, it has a profound effect on both angiogenesis and photoreceptor survival. notably Rb1/Vhl-DKO did not increase and instead reduced cleaved caspase-3 + cells at P8 or P18 by about 2-fold ( Figure 2 , E and F). Western blots of P14 retinal lysates confirmed this reduction ( Figure 3 , A and B). Analysis of several autophagy regulators revealed that while Becn1 was not affected in the DKO retina, Atg5, Atg7, Bnip3, and Bnip3L were induced and the microtubule-associated proteins 1A/1B light chain 3B (MAP1LC3B) II/I ratio increased ( Figure 3 , A and B). Thus, the dramatic loss of photoreceptors in the DKO tissue is due to both autophagy and apoptosis, supporting the idea that Rb1 may repress retinal Hif targets. Vhl-KO alone also induced autophagy without apoptosis in the retina (Supplemental Figure  1 , A and B), and likely autophagy causes the photoreceptor loss in the Vhl -/retina at late stage (20, 21) . One allele of Rb1 was sufficient to suppress the expression of Atg5, Atg7, and Bnip3L in the Vhl -/retina (Supplemental Figure 1, A and B ), confirming Rb1 can directly inhibit Hif-induced autophagy. Indeed, Rb1 +/-Vhl -/retina had fewer rod photoreceptors than Vhl -/retina ( Figure 2 , A and B).
To further understand why Rb1/Vhl loss induces extensive retinal angiogenesis and photoreceptor death, we performed RNA-sequencing from P14 WT, Vhl -/-, Rb1 +/-Vhl -/-, and Rb1 -/-Vhl -/retinas. We analyzed differentially expressed genes (DEGs) and identified 1393 Vhl -/--related DEGs compared with WT. There were 820 down-and 573 upregulated genes (Supplemental Table 1 ). Gene list enrichment analysis indicated that the most enriched downregulated DEGs were in the pathways of ECM-receptor interaction; some photoreceptor genes were also slightly downregulated, including Grk1, Slc24a1, Gnat1, and Cngb1. The most enriched upregulated DEGs were in the pathways of ribosome biogenesis and oxidative phosphorylation, consistent with a previous report that Vhl inhibits ribosome biogenesis (45) and the vascular defects in the Vhl -/retina ( Figure 1 , A-C). Only a few Hif pathway genes were slightly upregulated in P14 Vhl -/retina, including Nos3 and Hmox1 (Supplemental Table 1 ), consistent with the presence of an inhibitor of Hif targets.
We further identified 890 Rb1 +/-Vhl -/--related DEGs and 4686 DKO-related DEGs, compared with Vhl -/retinas (Supplemental Table 1 ). For DKO retinas, the most enriched downregulated DEGs were in the pathways of oxidative phosphorylation and phototransduction; the most enriched upregulated DEGs were in the pathways of cell cycle, ECM-receptor interaction, PI3K-Akt, and Hif-1 ( Figure 3 , C and D). For Rb1 +/-Vhl -/retinas, the most enriched downregulated DEGs were in ribosome biogenesis, and the most enriched upregulated DEGs were in the pathways of ECM-receptor interaction, Hif-1, and PI3K-Akt. Notably, cell cycle genes were not enriched in the Rb1 +/-Vhl -/retinas ( Figure 3 , C and D). These RNA-sequencing data support the notion that Rb family members constrain induction of Hif-1 targets in the absence of Vhl.
Real-time PCR (RT-PCR) results supported altered expression of several Hif targets, such as Bnip3, Epo, Tek, Vegfa, and Kdr. Deleting Rb1 in Vhl -/retina increased expression of these genes 1.7-to 2.7-fold ( Figure 3E To test whether Rb1 directly regulates these genes in the retina, we ran ChIP assays. It was difficult to obtain enough pure knockout material from the peripheral Cre-positive region of the α-Cre Vhl fl/fl retina; thus we assessed Rb1 binding in WT retinal explants left untreated or exposed to CoCl 2 , which mimics hypoxia and induces Hif-1α accumulation (Supplemental Figure 5 ) (46) . Consistent with a previous analysis in fetal liver (37) , Rb1 was bound to the promoters of several Hif targets, such as Bnip3, Epo, Kdr, Tek, and Vegfa ( Figure 3F ). CoCl 2 treatment did not increase Rb1 binding ( Figure 3F ), suggesting that Hif-1α might not directly recruit Rb1 to these targets; instead and most likely, Rb1 binds E2f, which was recruited to the promoter of these targets, and recruits some cofactors that can bind and inhibit Hif protein or Hif-responsive element (37) .
Dual-luciferase reporter assay using HEK293T cells indicated that Rb1 can partially repress the transcription activity of the 198-bp promoter of Vegfa gene (~15% reduced compared with empty vector), the 938-bp promoter of Kdr gene (~55% reduced compared with the empty vector), and the 337-bp promoter of Tek gene (~35% reduced compared with the empty vector). Rb1 did not affect the shorter 213-bp promoter of Kdr ( Figure 3G ), suggesting a requirement for upstream regions. The result with the Vegfa 198bp promoter-luc reporter is consistent with results showing that E2f1 can regulate a similar reporter (47) .
Together, the above genetic and molecular analyses reveal Rb1 inhibits a subset of Hif-1 target genes, providing a logical mechanism to explain why the Vhl -/retina does not exhibit vessel overgrowth phenotypes, such as RAP or RCH. , and asterisks indicate significant differences between WT and indicated genotypes in B and E; or between IgG no CoCl 2 treatment and other indicated treatments in F, between pSG5L-HA-RB and pSG5L vector in G (*P < 0.05, **P < 0.01, 1-way ANOVA followed by Bonferroni's correction).
Rb1 suppresses the SVP in the Ccnd1 -/retina. To further examine the effect of Rb1 on Hif targets, we asked whether activating Rb1 represses these genes. Hif is expressed in WT retinal progenitors (21) and is required for retinal vascular development (48) . There are very high levels of cyclin D1 in retinal progenitors, which activate Cdk4 and Cdk6 kinase that phosphorylate and inhibit Rb1 (41) . Deleting Ccnd1 activates Rb1, and we hypothesized that it may inhibit Hif action and impede angiogenesis in the developing retina. Indeed, Ccnd1 -/mice had retinal angiogenesis defects: There was almost no DVP or IVP, and the SVP had not reached to the peripheral retina by P18 (Figure 4 , A-D).
Ccnd1 loss reduces retinal progenitor proliferation, so these vascular effects might be an indirect consequence of hypocellularity rather than Rb1-mediated repression of Hif targets, similar to the Rd1 retinal degeneration retina (49) . To examine that possibility, we took 3 approaches. First, horizontal sections of P18 Ccnd1 -/retina were stained for all 7 retinal cell types (Supplemental Figure 6 ). Although the retinal thickness was reduced as reported (41), clearly all retinal cell types formed and were properly laminated, excluding the possibility that neuronal developmental delay or defects caused the vascular defects.
Second, we studied the peripheral α-Cre E2f1 -/-E2f2 -/-E2f3 fl/fl retina because removing E2f1, -2, and -3 also reduces retinal progenitors and to an even greater extent than Ccnd1 -/- (50) . Notably, both SVP and DVP developed normally, although the IVP developed late (Figure 4 , A-D). Thus, severe effects on the SVP and DVP are uniquely associated with Ccnd1 -/and not with hypocellularity per se.
Third, we tested directly whether suppression of angiogenesis in the Ccnd1 -/retina requires Rb1. There was no difference of body weight between Ccnd1 -/and α-Cre Ccnd1 -/-Rb1 fl/fl mice (Supplemental Figure  7) , indicating the overall development is similar between these genotypes. The Ccnd1/Rb1-null retina still lacked the DVP and IVP, but strikingly, it had a completely normal SVP (Figure 4 , A-D). Differentiating Rb1 -/retinal cells undergo ectopic division and some cell types die. It is unlikely that these events promote SVP development because Bax-driven cell death in the Rb1 -/retina actually impedes IVP and DVP development (40) . To validate that interpretation, we further assessed the effect of Rb1 heterozygosity, which does not perturb any aspect of retinal development (34) . As with Rb1 loss, there was a complete rescue of the SVP in the Ccdn1 -/-Rb1 +/retina ( Figure 4 , A-D). Thus the SVP defects in Ccdn1 -/retina were caused by activated Rb1. Notably, the expression of several Hif targets was significantly repressed in Ccnd1 -/retina, which was rescued by removing 1 or 2 copies of Rb1, whereas only Bnip3 was slightly reduced in the E2f1-3-null retina that had a normal SVP ( Figure 4E ). The mechanism of the DVP/IVP defects in the Ccdn1 -/retina remains unclear but may reflect inhibition of Hif-1 targets by Rb1 relatives or Rb1-independent functions of cyclin D1, such as transcriptional regulation of Notch pathway (51) .
In summary, multiple genetic and molecular analyses suggest that inhibition of Rb1 by cyclin D1 in retinal progenitors is critical to permit Hif to promote normal SVP development.
Vhl is required for retinoblastoma in the Rb1/Rbl1-null retina. Because Rb1 inhibited Hif targets in the Vhl -/retina, removing another Rb family member, such as Rbl1, might further enhance vascular overgrowth. Before addressing that hypothesis, we first asked whether Vhl affects any phenotypes caused by Rb1/Rbl1 loss. The most striking difference between Rb1 and Rb1/Rbl1 loss is that only the latter causes murine retinoblastoma (34, 35) . Vhl is a potent tumor suppressor in other tissues, suggesting that Vhl deletion might enhance retinoblastoma penetrance (13) . However, whereas both Hif-1α and Hif-2α promote angiogenesis, the latter promotes while the former inhibits cancer progression (52) . Notably, longterm analysis of a large cohort of mutant mice revealed that the Rb/Rbl1/Vhl-triple knockout (TKO) retina is resistant to retinoblastoma ( Figure 5A ).
All 7 retinal cell types in Rb1/Rbl1-DKO retina fail to exit the cell cycle and divide ectopically (34, 44) . Even though there were many Mki67 + dividing cells at P8 and P18 (Supplemental Figure 4 ), they gradually exited the cell cycle when they fully developed; thus they were not tumor cells. Indeed, there were almost no Mki67 + cells at P138 in TKO retina (Supplemental Figure 8 ). These data imply predominance of Hif-1α in the cell of origin of retinoblastoma. Prior analysis of nascent tumors revealed that Rb1/Rbl1-null murine retinoblastoma arises from ectopically dividing amacrine cells, which have an intrinsically high resistance to apoptosis (34) . Therefore, we were interested in any effects of Vhl loss on this lineage.
First, we assessed whether Vhl loss compromised the survival of the tumor cell of origin. The Rb1/ Rbl1-null retina loses all ganglion, rod, cone, and rod bipolar cells but retains ectopically dividing amacrine, horizontal, and Müller cells (34) . The TKO retina lost the same cell types as the Rb1/Rbl1-null tissue (Figure 2, A and B ). In addition, while Vhl loss reduced the extent of cleaved caspase-3 + cells, akin to the Rb1/ Vhl-DKO retina (Figure 2 , E and F), there was increased autophagy, as Atg5, Atg7, Bnip3/Bnip3L, and the MAPLC3B II/I ratio increased (Figure 3, A and B) . Notably, however, the TKO retina retained amacrine, horizontal, and Müller cells (Figure 2 , C and D), indicating that Vhl is not required for the survival of the retinoblastoma cell of origin.
Indeed, there were actually more amacrine cells, and more Müller glia, when Vhl was missing ( The requirement for Vhl to maintain ectopic division in Rb1/Rbl1-null amacrine cells explains the absence of tumorigenesis in the TKO tissue. In line with these cellular effects, RNA-sequencing analysis identified 4077 TKO-related DEGs, compared with Rb1/Rbl1-DKO retinas (Supplemental Table 1 ). The most enriched downregulated DEGs were in the pathways of DNA replication and cell cycle; the most enriched upregulated DEGs were in the pathways of ribosome biogenesis, PI3K-Akt, ECM-receptor interaction, and Hif-1 ( Figure 5B and Figure 3D ). Indeed, TKO retina had lower expression of cell cycle genes, such as Cdk2, Ccne1, E2f1, and Tyms, although the expression of Myc family and some cell death genes (Bax, Becn1, and Bbc3) was similar between the 2 genotypes ( Figure 5C ).
Vhl loss can cause a senescent-like phenotype in mouse embryonic fibroblasts (53) . However, we did not identify any signs of senescence in Vhl-KO, Rb1/Vhl-DKO, and Rb1/Rbl1/Vhl-TKO retinas ( Figure 5D ). It will be interesting to deduce how Vhl loss influences cell cycle gene expression, but our major goal here was to address the role of the Rb family in constraining Vhl -/--induced angiogenesis. The complete absence of cancer in the TKO retina removed a confounding factor in the pursuit of this goal.
Rb1/Rbl1/Vhl-TKO retina forms RCH/RAP-like lesions. Next, therefore, we asked whether deleting Rbl1 affects vessel growth in the Rb1/Vhl-null retina. Indeed, IB4 staining revealed that all 51 eyeballs of TKO mice we analyzed form RCH-like lesions after P10 ( Figure 6, A and B) . Human RCH generally locates at the inner retinal surface, but the RCH-like lesions described here were always in the subretinal space, resembling stage II-III RAPs (5, 6) . FFA revealed subretinal vascular leakage at late stages, even though the images were not clear as the fluorescein was blocked by the persistent hyaloid vessels (Figure 6C, arrows) . Histologically, the RAP lesion was a vascular mass between the neuronal retina and the RPE layer (Figure 6D) . RPE cells beside RAPs often degenerated because there were many RPE vacuoles ( Figure 6D , asterisks). Thus, in some areas, RAPs could penetrate the RPE layer and grow into the choroid, likely to form retinal-choroidal anastomosis (Figure 6D, arrowheads) . Indeed, there were almost no RPE65 + RPE cells around RAP lesions ( Figure 6E ). Inside the RAP lesion, similar to RCH, there were many vacuolated "foamy" stromal cells ( Figure 6D, arrow) , likely because Vhl deficiency induced abnormal lipid metabolism, as also seen in the CCRCC and liver hemangioblastoma (54) . The foamy stromal cells are considered the true tumor cells in hemangioblastoma (12) .
Next, we sought to define the cellular origin of the foamy stromal cells in the RAP/RCH-like lesions. They were mainly composed of Sox9 + cells, without any Ap2a + amacrine cells, suggesting that they originated from Müller glia ( Figure 7A ). Consistent with this notion, we found that these lesions expressed high levels of Lgals3 ( Figure 7A ), which is expressed mainly in Sox9 + Müller glial cells, but not Ap2a + amacrine or Aif1 + (also called Iba1) microglial cells in WT retina ( Figure 7B ). Western blot and RT-PCR also confirmed this finding ( Figure 3 , A and B, and Figure 5C ). Lgals3 is expressed in all stromal cells of human cerebellar hemangioblastoma (55) . High-magnification images showed that Lgals3 + cells were the stromal cells, and they never costained with IB4 + endothelial cells ( Figure 7A, blowup) . Lgals3 also marks active microglial cells (56) , but costaining with Aif1 indicated that although some microglia were present, most cells in the RAP lesions were Aif1 -, further supporting a Müller glia origin ( Figure 7A ). RPE cells also express Sox9 (57); thus it was possible that RPE cells are the cellular origin of the RAP lesions. However, 4 findings countered this idea. First, there were almost no RPE65 + cells in RAP lesions (Figure 6E) . Second, RPE cells did not express Lgals3 (Figure 7B, arrow) . Third, laser capture of microdissected RAP lesions followed by PCR analysis of genomic DNA confirmed Cre-mediated recombination of Rb1 in the RAP lesions, confirming the retinal origin of the lesions (260-bp band in Figure 7C ). Some un-recombined bands (670 bp) may derive from blood vascular cells. Finally, we used Z/Red Cre-indicator mice to lineage-trace knockout cells (58) and found many DsRed + cells in the RAP lesions, indicating that the cell of origin derives from the Cre-expressing retinal cells ( Figure 7D ). Thus, deleting Vhl in the Rb1/Rbl1-null retina prevented amacrine cell transformation but induced RCH/RAP-like lesions that originate from Müller glial cells.
Discussion
The Vhl -/retina does not exhibit vascular overgrowth, such as RAP or RCH (20, 21) , but it is unclear how Hif target expression is suppressed. Our data now pinpoint Rb1 as the critical angiogenic inhibitor. Thus, the Rb1/Vhl-DKO retina exhibits striking levels of angiogenesis. Multiple pieces of evidence argue that this is not an indirect consequence of other cellular effects of Rb1 loss. First, Bax-driven apoptosis in the Rb1 -/retina actually impedes vessel growth (40) . Second, Rb1 heterozygosity does not perturb retinal development (34) but stimulates vessel growth in the Vhl -/retina. Third, deleting E2f1 completely rescues ectopic division, apoptosis, and abnormal lamination in the Rb1 -/retina (40), yet it does not reduce the excessive vessel growth in the DKO retina. Fourth, Hif can also stimulate autophagy, and removing Rb1 and Vhl triggers autophagic death of photoreceptors. Fifth, deleting Rb1 induces several Hif targets that drive both angiogenesis and autophagy. Finally, ChIP assays show that Rb1 protein binds to the promoters of several Hif targets in vivo, and reporter assays indicated that Rb1 could partially inhibit their transcription. Together, these data present a strong case that Rb1 directly inhibits Hif target expression in the retina and explains why vascular growth is constrained in the Vhl -/murine tissue. In addition, activating Rb1 in Ccnd1 -/retina suppresses Hif target expression and impedes SVP development, suggesting that Rb1 is necessary and sufficient to suppress Hif targets.
Our data indicate that in the Vhl -/retina, Rb1 is haploinsufficient with respect to blocking either angiogenesis or autophagy. This finding is intriguing given that the Rb1 +/retina is normal (34) . Rb1 is one of the classical tumor suppressor genes, which are thought to require mutation or loss of both alleles to facilitate tumor progression (59) . However, it has become clear that haploinsufficiency may contribute to tumorigenesis without loss of heterozygosity, such as is the case for Brca1, Brca2, and Tp53 (59) . Rb1 haploinsufficiency has been associated with increased genomic instability in premalignant osteoblasts (60) and fibroblasts (61) . Potentially, therefore, some of the phenotypes in patients with VHL might be related to partial reduction in Rb1 levels.
We find that Vhl loss induces retinal autophagy, which is the likely reason for delayed, partial loss of photoreceptors in the Vhl -/retina (20, 21) . Rb1 or Rb/Rbl1 loss triggers apoptosis of certain retinal neurons (34, 35) , but we find that Vhl loss partially suppresses apoptosis in the Rb1 -/and Rb1/Rbl1-null retina. This suppression may be linked to enhanced autophagy (62) . Our data suggest that the combination of residual apoptosis plus enhanced autophagy contributes to synthetic lethality in Rb1/Vhl-DKO rods and cones. It is also intriguing that inhibitory neurons and Müller glia can escape apoptosis or autophagy, but excitatory neurons die in both conditions. This finding has important implications in understanding the pathogenesis of retinal diseases. They have common risk factors, such as smoking, which can inactivate Rb1 (63), and oxidative stress, which can activate autophagy (64) . In addition, although Vhl loss can induce cell cycle arrest of Rb1-null or Rb1/Rbl1-null amacrine cells, it seems to enhance division in the Müller glia. This could contribute to reactive gliosis in some vascular retinal diseases.
Although Vhl is a well-known tumor suppressor, its deletion completely suppresses retinoblastoma in the Rb1/Rbl1-null retina. These tumors arise from ectopically dividing amacrine cells (34) , so the quiescence of Rb1/Rbl1/Vhl-null amacrine cells as early as P18 provides a logical explanation for tumor suppression. Although both Hif-1α and Hif-2α are stabilized in Vhl-null retina, Hif-1α is the major mediator of retinal phenotypes (20, 21) . In many instances Hif-1α acts as a tumor suppressor while Hif-2α promotes tumor progression (52) . For example, Hif-2α, rather than Hif-1α, is the key driver of renal cancer progression (65). Thus, it is possible Hif-1α inhibits retinoblastoma initiation in the Rb1/Rbl1-null retina.
The absence of cancer in the Rb1/Rbl1/Vhl-TKO retina was an advantage because it meant that any new vascular phenotypes relative to the TKO tissue could not be an indirect consequence of tumorigenesis. Deleting all 3 genes generated a mouse model with subretinal RCH-or RAP-like lesions. Scl-Cre ER -induced Vhl deletion in hemangioblasts can generate some features of early-stage RCH; however, histologically there are no hemangioblastoma structures and neovascularization in the retina, except some foamy stromal cell clusters (27) . Vhl loss alone does not induce kidney VHL disease, but Rb1/p53/Vhl TKO induces a CCRCC mouse model (29) . Similarly, our results show that the RCH-like lesions can originate from retinal cells, but Vhl loss alone may not be sufficient. The foamy cells in the RCH-like lesions we detected originated from Müller glia, which express high levels of Sox9. Consistent with a report that Lgals3 is a diagnostic marker for brain hemangioblastoma (55), we found RCH-like lesions express Lgals3, indicating that it is also a possible biomarker for diagnosing human RCH. Because most eyes of RCH patients do not need to be enucleated, it has remained unclear whether human RCH has a glial component. An early study referred to an astrocytic component of RCH (17) . More recently, using histological, immunohistochemical, and ultrastructural methods to study 3 cases where samples were available, 2 groups reported that GFAP + glial cells are a major component of human RCH (18, 19) . The cell of origin of human RCH needs further investigation, but our work supports the notion that foamy stromal cells may originate from Müller glia.
The RCH/RAP-like lesions are located in the subretinal space and can induce degeneration of the RPE and invade into choroid. These features are similar to advanced stage III human RAP. Early-stage RAP is observed in several mouse mutants, including mice with ONL-specific Vegf overexpression (7) or inactivation of Vldlr (9) or Srf (10) and in Bst-mutant (8) and NRV2-mutant mice (11). The retinal neovascularization in these mice is similar to stage I-II RAPs and may be related to local Vegf upregulation. However, there are no obvious stromal cells, and no angiomatous complexes in the later stages, which are quite different from the pathological changes in late-stage human RAP (5, 6) . For the same reasons as RCH, few reports have described the cellular features of human RAP. Recent studies found that RAP is a circumscribed intraretinal angiomatous complex within the outer part of the neurosensory retina, composed of endothelial cells and stromal cells. Endothelial cells within the RAP lesion stained positively for vWF and VEGF (5, 6) . However, retinal cell markers (neuronal or glial) were not stained in the RAP lesion; thus it remains unclear whether there is a glial component. Our work suggests that glia is a major component of RAP-like structures in mice. Based on these data, it will be interesting for the field to revisit the question of the origin of stromal cells in human RAP.
In summary, our work exposes previously unrecognized roles for the Rb family in constraining retinal angiogenesis and autophagy and establishes a potentially new mouse model of RCH/RAP, which will be a useful tool in dissecting the pathogenesis of these disorders, optimizing therapeutic strategies, and stimulating further work to address the origins of stromal cells in the human disease.
Methods
Mouse strains and genotyping. Mice were treated according to institutional and national guidelines. All procedures were performed in compliance with the Association for Research in Vision and Ophthalmology (ARVO) statement for the use of animals in ophthalmic and visual research. α-Cre mice (P. Gruss, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany), Ccnd1 -/mice (The Jackson Laboratory, stock 002935), E2f1 -/mice (M. Greenberg, Harvard Medical School, Boston, Massachusetts, USA), E2f2 -/mice (G. Leone, The Ohio State University, Columbus, Ohio, USA), E2f3 fl/fl mice (G. Leone), Rb1 fl/fl mice (A. Berns, the Netherlands Cancer Institute, Plesmanlaan, Amsterdam, the Netherlands), Rbl1 -/-(p107 -/-) mice (M. Rudnicki, University of Ottawa, Ottawa, Ontario, Canada), Vhl fl/fl mice (The Jackson Laboratory, stock 004081), and Z/Red mice (The Jackson Laboratory, stock 005438) were maintained on a mixed background. Different genotypes were compared within the same litter and across at least 3 litters. We have not noted any phenotypic differences in separate litters. Genotyping was performed as before and as per The Jackson Laboratory guideline.
Histology, immunofluorescence, and measurements. Eyeballs were fixed for 1 hour at 4°C in 4% paraformaldehyde, embedded in OCT (Tissue-Tek 4583), frozen on dry ice, and cut into 12-to 14-μm sections on Superfrost slides. The following antibodies were used: Aif1 (Wako 019-19741), Ap2a (Santa Cruz Biotechnology SC-8975), Calb1 (MilliporeSigma C9848), cleaved caspase-3 (Cell Signaling Technology 9661), Arr3 (MilliporeSigma AB15282), Crx (C.Y. Gregory-Evans, Imperial College School of Medicine, London, United Kingdom) (66), DsRed (Clontech 632496), Glul (MilliporeSigma MAB302), Lgals3 (Santa Cruz Biotechnology SC-19283), Mki67 (BD Pharmingen 550609), One-cut2 (R&D Systems AF6294), Pax6 (DSHB AB-528427), PH3 (Santa Cruz Biotechnology SC-8656), Pou4f2 (Santa Cruz Biotechnology SC-6062), PKC-α (MilliporeSigma P5704), rhodopsin (Santa Cruz Biotechnology SC-57433), RPE65 (Abcam ab13826), Sox9 (MilliporeSigma AB5535), and Thrb2 (D. Forrest, NIH) (67) . Vascular endothelial cells were labeled by FITC-conjugated IB4 (MilliporeSigma L2895). Antigen retrieval was performed as described (44) . Primary antibodies or labeled cells were visualized using donkey anti-mouse, donkey anti-rabbit, and donkey anti-goat antibodies conjugated with Alexa Fluor 488, Alexa Fluor 568, or Alexa Fluor 647 (1:1000; Molecular Probes, Thermo Fisher Scientific). Nuclei were counterstained with DAPI (MilliporeSigma D9542) and mounted with Mowiol (MilliporeSigma 81381). Validations of the primary antibodies are provided on the manufacturers' websites or in the referenced citations.
For whole-mount staining, eyeballs were enucleated and incubated for 30 minutes in 4% paraformaldehyde. The retinas were incubated at 4°C with FITC-conjugated IB4 (MilliporeSigma L2895) and DAPI in PBS for 1-2 days. After brief washes with PBS, radial cuts were made to divide the retina into 4 quadrants to flatten the retina, and flat retinas were mounted with Mowiol.
Stained sections and slides were analyzed using a Zeiss Axio Imager Z2 fluorescence microscope and Nikon C1si confocal microscope. ImageJ (NIH) was used for cell counting. The positive cells of active caspase-3, Mki67, PH3, and cell type markers were counted manually. For vascular blood vessel analysis, representative images were analyzed using the AngioTool (National Cancer Institute) to assess the density of the vascular plexus. In brief, at least three ×200 magnification images (320 × 320 μm FOV per retina) per eye and 3 eyes from the same genotypes of different litters were counted. To compare the vascular density of the Rb1/Vhl-DKO retina to other genotypes, we used vascular images taken from a similar depth below the GCL to represent the IVP and DVP for the Rb1/Vhl-DKO retina.
To generate 3D images for retinal vasculature, 40 Z-stack images were taken using a Nikon C1si confocal microscope, and ImageJ was used to convert these Z-stack images into a 3D video.
Senescence-associated β-galactosidase staining. Human lung cancer A549 cells (ATCC CCL-185) on coverslips (with or without pretreatment of etoposide 1 μM for 4 days) and frozen horizontal retinal sections were stained for β-galactosidase at pH 6.0 using the senescence-associated β-galactosidase staining kit (Cell Signaling Technology 9860). Color images were taken using an Olympus BX61 microscope. For each genotype, at least 3 retinas were analyzed.
H&E staining for frozen sections. Slides were rinsed once with 1× PBS, then stained with Mayer's hematoxylin for 5 minutes. They were then rinsed with running tap water for 4 minutes, dehydrated to 95% ethanol by dipping for 10-20 seconds in alcoholic eosin, and then dehydrated through at least 2 more changes of 95% ethanol and 100% ethanol. They were then cleared through 3 changes of xylene and mounted on coverslips with Permount (Thermo Fisher Scientific SP15-100). Color images were taken using an Olympus BX61 microscope.
RNA extraction, reverse transcription, and quantitative real-time PCR. Total RNA was isolated from peripheral retinas (α-Cre expression area) using TRIzol reagent (Invitrogen, Thermo Fisher Scientific) or RNeasy Mini Kit (Qiagen) followed by digestion with RNAse-free DNAse (DNA-free, Invitrogen, Thermo Fisher Scientific) to remove DNA contamination. After quantification by a NanoDrop (NanoDrop Technologies), first-strand cDNA was synthesized from 0.2 to 1.0 μg of total RNA using the RT Reagent Kit with gDNA Eraser (TaKa-Ra) or SuperScript II first-strand synthesis system (Invitrogen, Thermo Fisher Scientific). PCR primers are listed in Supplemental Table 2 . Real-time quantitative PCR was performed using the qTOWER 2.2 PCR machine (Analytik Jena) or C1000 touch Thermal Cycler (Bio-Rad). Tests were run in duplicate on 3 separate biological samples with EvaGreen PCR Supermix (SsoFast, Bio-Rad) or SYBR Green PCR Master Mix (Applied Biosystems, Thermo Fisher Scientific). PCR consisted of 40 cycles of denaturation at 95°C for 15 seconds and annealing and extension at 55°C for 30 seconds. An additional cycle (95°C, 15 seconds) generated a dissociation curve to confirm a single product. Values obtained for test RNAs were normalized to β-actin mRNA levels.
RNA-sequencing. Total RNAs were extracted from dissected α-Cre-expressing peripheral retinas using TRIzol (Invitrogen, Thermo Fisher Scientific) and treated with RNAse-free DNAse I (New England Biolabs) to remove genomic DNA. The yield of total RNA was assessed using NanoDrop (Thermo Fisher Scientific). The cDNA libraries were prepared using an Illumina TruSeq RNA sample preparation kit, and the quality was assessed using an Agilent 2100 Bioanalyzer (Agilent Technologies). For sequencing, the cDNA libraries were loaded on an Illumina HiSeq 2500 at Biomaker (Beijing, China). The raw sequence reads in FASTQ format were processed and analyzed as previously reported (68, 69) . Briefly, the sequencing quality was first assessed using FastQC, and poor-quality 5′ end reads were trimmed using a Perl script and then mapped onto mouse genome (mm9) using TopHat2, allowing for up to 2 mismatches as default settings. Reads that were mapped onto multiple genomic locations were discarded, and a custom R script was used to calculate the reads per kilobase million (RPKM) of each gene and obtain the expression profile of each sample. The expression fold change of each coding gene of mutated retinas (including Vhl -/-, Rb1 +/-Vhl -/-, Rb1/Vhl-DKO, Rb1/Rbl1-DKO, and Rb1/Rbl1/Vhl-TKO) retina compared with WT retina was calculated using the following formula: Fold change = (RPKM + 1) mutated / (RPKM + 1) WT . The genes for which expression fold changes were greater than 1.54 or less than 0.65 were selected as the mutated related DEGs. The heatmap was generated using Heatmapper (70) . The function enrichment of DEGs was performed using Enrichr (71, 72) ; the pathways with adjusted P value less than 0.05 were chosen to report.
Ex vivo retinal explant cultures and ChIP. Retinal explants obtained from P8 WT C57/BL mice were cultured using a modified protocol from previously described methods (73, 74) . Briefly, both eyes were enucleated and retinas were carefully peeled away from the RPE, and radial cuts were made to flatten the retina. The flattened retina was transferred to the membrane of a Millicell insert (MilliporeSigma, PICM03050) with the photoreceptors facing down. The insert was placed into the wells of a 6-well plate (Costar 3516, Corning); each contained 1300 μL of retinal explant media, which was replaced every 2 days and was maintained in a 37°C incubator with 5% CO 2 for 3 days. The retinal explant basal medium was serum-free and made from Neurobasal A, DMEM/F12 medium, and N2/B27 supplements (Life Technologies). Cultured explants were exposed to 300 μM CoCl 2 (MilliporeSigma) treatment or kept as PBS-treated controls. The ChIP assay was performed using Magna ChIP A/G Chromatin Immunoprecipitation Kit (Millipore Temecula) according to the manufacturer's instructions. Briefly, retinal explants treated with or without CoCl 2 were cut into small pieces and then cross-linked for 20 minutes by addition of formaldehyde to a final concentration of 1%. The cross-linking was stopped by adding 1/20 volume of 2.5 M glycine and lysed by SDS lysis buffer. Then cell lysate was sonicated and immunoprecipitated with antibodies specific to Rb1 (1:100, Cell Signaling Technology, 9309) or negative control IgG. After protein/DNA complexes were eluted, reverse cross-linked to free DNA, and purified, the specific DNA fragments were quantified using real-time PCR and normalized to input from the same sample. The primer sequences for the promoters analyzed are provided in Supplemental Table 3 .
Plasmid construction and reporter assays. pREP4-Luc vector was from K. Zhao (NIH) (75) . A 445-bp mouse DNA fragment from -198 to +247 around Vegfa transcriptional start site (TSS) was amplified using the primers Vegfa-p500-f1 and Vegfa-p500-r1; a 402-bp mouse DNA fragment from -213 to +189 around Kdr TSS was amplified using the primers Vegfr2-p400-f1 and Vegfr2-p400-r1; a 1127-bp mouse DNA fragment from -938 to +189 around Kdr TSS was amplified using the primers Kdrf 1127 and Vegfr2-p400-r1; a 597-bp DNA fragment from -337 to +260 around Tek TSS was amplified using the primers Tie2-p500-f1 and Tie2-p500-r1. The sequences of the abovementioned primers are as follows: Vegfa-p500-f1 (5′-CCCG-GTACCgtttgaaggggtgcacagat-3′, KpnI site underlined); Vegfa-p500-r1 (5′-GGCAAGCTTAACCGTTGG-CACGATTTAAG-3′, HindIII site underlined); Vegfr2-p400-f1 (5′-CCCGGTACCttgctctcagatgcgacttg-3′, KpnI site underlined); Vegfr2-p400-r1 (5′-GGCAAGCTTAAGTCACAGAGGCGGTATGC-3′, HindIII site underlined); Kdrf 1127 (5′-CCCGGTACCaccggtttcctctttgttcc-3′, KpnI site underlined); Tie2-p500-f1 (5′-CCCGGTACCgctgagagctgacctcaacc-3′, KpnI site underlined); and Tie2-p500-r1 (5′-GGCAAGCT-TATGGTCCACTCGCTCTTGTT-3′, HindIII site underlined).
The amplified DNA fragments were digested with KpnI and HindIII, ligated to KpnI/HindIII-digested pREP4-Luc to generate Vegfa-198bp-Luc, Kdr 213bp-luc, Kdr 938bp-luc, and Tek-337bp-luc. The inserts were confirmed by DNA sequencing. pSG5L-HA-RB and pSG5L vectors were from William Sellers (Broad Institute, Cambridge, Massachusetts, USA) (76) . HEK293T cells (ATCC CRL-11268) were transfected with the pREP4-Luc vectors and the pSG5L-HA-RB or pSG5L vectors using Lipofectamine 2000 (Invitrogen, Thermo Fisher Scientific). In transient assays, 0.01 μg of renilla Luc plasmid was included to normalize transfection efficiency. Dual-luciferase assays were performed using Dual-Luciferase Reporter Assay system (Promega E1901) as described (77) .
Laser capture and recombined PCR of floxed Rb1 gene. RAP lesions were dissected from 10-μm H&E sections using the Zeiss PALM MicroBeam system and captured into a tube with 10 μL of the buffer (1 mM EDTA; 20 mM Tris [pH 8]) containing 2 mg/mL proteinase K. Cells were incubated at 55°C overnight in 10 μL of capture buffer followed by heat inactivation of proteinase K at 99°C for 10 minutes. Two microliters of the buffer was used for each PCR. The PCR primers were Rb18 (5′-GGCGTGTGCATCAATG-3′) and Rb212 (5′-GAAAGGAAAGTCAGGGACATTGGG-3′).
Western blotting. Peripheral retinas were homogenized with a 30-gauge needle 5-10 times in 1× cell lysis buffer (Cell Signaling Technology 9803) with 0.1 mM PMSF, 1 μg/mL aprotinin, and 1 μg/mL leupeptin. Proteins were separated by SDS-PAGE, transferred to nitrocellulose or PVDF membranes, and analyzed using ODYSSEY Infrared Imaging System (LI-COR) with antibodies against active caspase-3 (Cell Signaling Technology 9661), Atg5 (Santa Cruz Biotechnology SC-33210), Atg7 (Santa Cruz Biotechnology SC-33211), Becn1 (Cell Signaling Technology 3495S), Bnip3 (Cell Signaling Technology 3769), Bnip3L (Santa Cruz Biotechnology SC-28240), Hif-1α (MilliporeSigma 04-1006), Kdr (MilliporeSigma 07-716-1), Lgals3 (Santa Cruz Biotechnology SC-19283), MAP1LC3B (Cell Signaling Technology 2775), Vegfa (Santa Cruz Biotechnology SC-507), and β-actin (MilliporeSigma A5441).
Retroorbital injection of FITC-dextran. FITC-dextran (MilliporeSigma FD2000S) was dissolved in double-distilled H 2 O at a concentration of 50 mg/mL, centrifuged at 10,000 g for 5 minutes, and collected as the supernatant. P18 mice were anesthetized with an intraperitoneal (IP) injection of 4.6% chloral hydrate (2.5 mL/kg). Then, 0.15 mL of FITC-dextran was injected into the lateral canthus of the left orbit using a 1-mL syringe and 30-gauge needle. Eyeballs were enucleated 1 minute after the injection. Retinal whole mounts were prepared and flattened with a coverslip and were photographed with Zeiss Axio Imager Z2 fluorescence microscope.
FFA. Fluorescein angiography was performed using a Micron III retinal imaging system or Heidelberg retina angiograph system. P14-P18 mice were anesthetized with an IP injection of 4.6% chloral hydrate (2.5 mL/kg), and the pupils were dilated by 0.1% tropicamide solution. Fluorescein images were captured at different time points after IP injection of 0.1 mL of 2% fluorescein sodium (Novartis).
Statistics. All data were presented as mean ± SD or mean ± SEM. KM survival curves were created and statistical analysis was performed using GraphPad Prism software (GraphPad Software). The results were analyzed by 1-way ANOVA followed by Bonferroni's correction for multiple comparisons and 2-tailed Student's t test for comparisons between 2 groups. The P value of KM curves was calculated by log-rank (Mantel-Cox) test.
Study approval. All animal procedures were reviewed and approved by the Ethical Review Committee of Animal Research of West China Hospital, Sichuan University, Chengdu, Sichuan province, China (AUP 2015001B), and performed in compliance with the ARVO statement for the use of animals in ophthalmic and visual research.
